股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
CYCC Cyclacel Pharmaceuticals Inc | -3,910,000.0 | -3,910,000.0 | -2,566,000.0 |
ANVS Annovis Bio Inc | -7,032,750.0 | -2,617,750.0 | |
PULM Pulmatrix Inc | -2,719,000.0 | -2,873,000.0 | -2,873,000.0 |
YMAB Y-mAbs Therapeutics Inc | -3,477,000.0 | -2,888,000.0 | |
CRDF Cardiff Oncology Inc | -7,740,000.0 | -7,820,000.0 | -2,997,000.0 |
LGVN Longeveron Inc | -3,086,000.0 | -3,133,000.0 | -3,009,000.0 |
VRPX Virpax Pharmaceuticals Inc | -3,011,480.0 | -3,011,480.0 | |
WINT Windtree Therapeutics Inc | -3,567,000.0 | -3,567,000.0 | -3,046,000.0 |
OCUP Ocuphire Pharma Inc | -5,716,000.0 | -3,340,000.0 | |
EXEL Exelixis Inc | 68,822,000.0 | 59,131,000.0 | -3,433,000.0 |
ADAP Adaptimmune Therapeutics PLC | -31,950,000.0 | -32,308,000.0 | -3,489,000.0 |
ATXS Astria Therapeutics Inc | -19,094,000.0 | -3,518,000.0 | |
LTRN Lantern Pharma Inc | -3,068,520.0 | -3,070,740.0 | -3,579,810.0 |
ARCT Arcturus Therapeutics Holdings Inc | -5,557,000.0 | -5,797,000.0 | -3,609,000.0 |
TKNO Alpha Teknova Inc | -2,892,000.0 | -3,204,000.0 | -3,628,000.0 |
MIST Milestone Pharmaceuticals Inc | -8,934,000.0 | -3,629,000.0 | |
MNOV MediciNova Inc | -3,868,250.0 | -3,860,640.0 | |
FEMY Femasys Inc | -4,568,120.0 | -4,658,280.0 | -3,880,110.0 |
STRO Sutro Biopharma Inc | -64,741,000.0 | -65,187,000.0 | -4,065,000.0 |
ANIK Anika Therapeutics Inc | -126,000.0 | -1,934,000.0 | -4,238,000.0 |
KTTA Pasithea Therapeutics Corp | -4,321,090.0 | -4,321,090.0 | -4,321,710.0 |
AVXL Anavex Life Sciences Corp | -11,656,000.0 | -4,379,000.0 | |
GH Guardant Health Inc | -30,284,000.0 | -37,218,000.0 | -4,430,000.0 |
NRSN Neurosense Therapeutics Ltd | -4,374,000.0 | -4,378,000.0 | -4,449,000.0 |
AEZS Aeterna Zentaris Inc | -4,290,000.0 | -4,295,000.0 | -4,471,000.0 |
HEPA Hepion Pharmaceuticals Inc | -9,001,780.0 | -9,002,120.0 | -4,498,200.0 |
COCP Cocrystal Pharma Inc | -4,503,000.0 | -4,511,000.0 | -4,511,000.0 |
MESO Mesoblast Ltd | 36,697,000.0 | 36,757,000.0 | -4,635,000.0 |
ETON Eton Pharmaceuticals Inc | -2,473,000.0 | -4,355,000.0 | -4,733,000.0 |
GRTX Galera Therapeutics Inc | -4,791,000.0 | -4,791,000.0 | |
NRIX Nurix Therapeutics Inc | -41,951,000.0 | -44,835,000.0 | -4,814,000.0 |
RVNC Revance Therapeutics Inc | -65,939,000.0 | -67,651,000.0 | -4,820,000.0 |
CRVS Corvus Pharmaceuticals Inc | -5,157,000.0 | -5,164,000.0 | |
CARA Cara Therapeutics Inc | -30,453,000.0 | -31,289,000.0 | -5,187,000.0 |
RLYB Rallybio Corp | -15,457,000.0 | -5,193,000.0 | |
TIL Instil Bio Inc | -14,392,000.0 | -14,392,000.0 | -5,212,000.0 |
ALRN Aileron Therapeutics Inc | -5,271,000.0 | -5,271,000.0 | |
MBIO Mustang Bio Inc | -5,321,000.0 | -5,272,000.0 | |
GOVX GeoVax Labs Inc | -5,683,730.0 | -5,683,730.0 | |
NEXI Neximmune Inc | -5,832,760.0 | -5,832,760.0 | -5,832,760.0 |
EYEN Eyenovia Inc | -6,322,200.0 | -6,467,430.0 | -5,853,150.0 |
ADMA ADMA Biologics Inc | -2,218,000.0 | -4,580,000.0 | -6,027,000.0 |
TNGX Tango Therapeutics Inc | -37,857,000.0 | -38,052,000.0 | -6,078,000.0 |
BNTC Benitec Biopharma Inc | -6,168,000.0 | -6,232,000.0 | |
NRBO NeuroBo Pharmaceuticals Inc | -6,442,000.0 | -6,447,000.0 | -6,447,000.0 |
RYTM Rhythm Pharmaceuticals Inc | -40,743,000.0 | -6,521,000.0 | |
BOLT Bolt Biotherapeutics Inc | -16,751,000.0 | -16,751,000.0 | -6,548,000.0 |
EVGN Evogene Ltd | -5,925,000.0 | -6,011,000.0 | -6,559,000.0 |
RZLT Rezolute Inc | -15,241,000.0 | -6,574,000.0 | |
APVO Aptevo Therapeutics Inc | -6,651,000.0 | -6,654,000.0 | |
FBRX Forte Biosciences Inc | -6,667,000.0 | -6,673,000.0 | -6,681,000.0 |
MBRX Moleculin Biotech Inc | -6,717,000.0 | -6,726,000.0 | |
CDTX Cidara Therapeutics Inc | -6,644,000.0 | -6,667,000.0 | -6,760,000.0 |
DARE Dare Bioscience Inc | -6,812,960.0 | -6,820,260.0 | -6,845,450.0 |
CDXS Codexis Inc | -7,789,000.0 | -8,919,000.0 | -7,071,000.0 |
CLNN Clene Inc. | -7,082,000.0 | -7,093,000.0 | -7,089,000.0 |
BCTX Briacell Therapeutics Corp | -7,401,310.0 | -7,401,310.0 | |
CUE Cue Biopharma Inc | -9,784,000.0 | -9,839,000.0 | -7,485,000.0 |
AVRO AVROBIO Inc | -7,569,000.0 | -7,569,000.0 | -7,539,000.0 |
XAIR Beyond Air Inc | -13,817,000.0 | -15,154,000.0 | -7,689,000.0 |
ITCI Intra-Cellular Therapies Inc | -34,116,000.0 | -7,948,000.0 | |
GHRS GH Research PLC | -8,085,000.0 | -8,109,000.0 | -8,019,000.0 |
RPTX Repare Therapeutics Inc | 11,932,000.0 | 11,932,000.0 | -8,051,000.0 |
BMRN Biomarin Pharmaceutical Inc | 46,971,000.0 | 12,867,000.0 | -8,131,000.0 |
NUVB Nuvation Bio Inc | -15,702,000.0 | -15,729,000.0 | -8,139,000.0 |
INAB IN8BIO, Inc. | -7,919,000.0 | -7,990,000.0 | -8,267,000.0 |
ALXO ALX Oncology Holdings Inc | -37,924,000.0 | -38,072,000.0 | -8,365,000.0 |
OMGA Omega Therapeutics Inc | -11,805,000.0 | -12,340,000.0 | -8,410,000.0 |
CRMD CorMedix Inc | -17,310,290.0 | -17,371,600.0 | -8,463,290.0 |
CAPR Capricor Therapeutics Inc | -1,268,440.0 | -1,932,760.0 | -8,480,210.0 |
LABP Landos Biopharma Inc | -8,498,000.0 | -8,495,000.0 | |
AQB AquaBounty Technologies Inc | -5,773,260.0 | -8,406,210.0 | -8,563,200.0 |
CMRX Chimerix Inc | -17,518,000.0 | -17,545,000.0 | -8,635,000.0 |
ENZ Enzo Biochem Inc | -8,938,000.0 | -8,963,000.0 | -8,966,000.0 |
AADI Aadi Bioscience Inc | -19,653,000.0 | -20,392,000.0 | -9,108,000.0 |
XLO Xilio Therapeutics Inc | -10,502,000.0 | -10,502,000.0 | -9,548,000.0 |
TELA TELA Bio Inc | -14,384,000.0 | -14,688,000.0 | -9,586,000.0 |
CADL Candel Therapeutics Inc | -8,438,000.0 | -8,445,000.0 | -9,700,000.0 |
ABCL Abcellera Biologics Inc | -41,708,000.0 | -65,848,000.0 | -9,748,000.0 |
INMB INmune Bio Inc | -7,476,000.0 | -9,846,000.0 | |
SRRK Scholar Rock Holding Corp | -49,785,000.0 | -49,808,000.0 | -9,876,000.0 |
CERT Certara Inc | 4,296,000.0 | 718,000.0 | -10,175,000.0 |
EYPT EyePoint Pharmaceuticals Inc | -31,171,000.0 | -32,365,000.0 | -10,250,000.0 |
MGTX MeiraGTx Holdings PLC | -36,741,000.0 | -38,419,000.0 | -10,384,000.0 |
NEO Neogenomics Inc | -25,915,000.0 | -31,500,000.0 | -10,574,000.0 |
VNDA Vanda Pharmaceuticals Inc | 7,569,000.0 | 7,562,000.0 | -10,663,000.0 |
VBIV VBI Vaccines Inc | -11,770,000.0 | -11,921,000.0 | -11,090,000.0 |
VRDN Viridian Therapeutics Inc | -45,223,000.0 | -45,223,000.0 | -11,186,000.0 |
TLIS Talis Biomedical Corp | -11,357,000.0 | -11,264,000.0 | -11,264,000.0 |
EQ Equillium Inc | -8,800,000.0 | -8,819,000.0 | -11,648,000.0 |
LUMO Lumos Pharma Inc | -12,894,000.0 | -11,899,000.0 | |
GTHX G1 Therapeutics Inc | -8,898,000.0 | -12,331,000.0 | |
UBX UNITY Biotechnology Inc | -5,183,000.0 | -12,373,000.0 | |
ATHA Athira Pharma Inc | -25,804,000.0 | -25,809,000.0 | -12,763,000.0 |
STOK Stoke Therapeutics Inc | -24,566,000.0 | -24,578,000.0 | -12,861,000.0 |
OTLK Outlook Therapeutics Inc | -13,032,170.0 | -13,035,350.0 | |
OCGN Ocugen Inc | -10,595,000.0 | -12,947,000.0 | -13,087,000.0 |
MRVI Maravai LifeSciences Holdings Inc | -8,467,000.0 | -14,132,000.0 | -13,271,000.0 |
ABSI Absci Corp | -17,863,000.0 | -17,863,000.0 | -13,360,000.0 |
ME 23andMe Holding Co. | -12,061,000.0 | -14,074,000.0 | -13,968,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例